Your browser doesn't support javascript.
loading
Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation.
Fundytus, A; Wells, J C; Sharma, S; Hopman, W M; Del Paggio, J C; Gyawali, B; Mukherji, D; Hammad, N; Pramesh, C S; Aggarwal, A; Sullivan, R; Booth, C M.
Afiliação
  • Fundytus A; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Wells JC; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Sharma S; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.
  • Hopman WM; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Del Paggio JC; Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
  • Gyawali B; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Mukherji D; American University of Beirut Medical Center, Beirut, Lebanon.
  • Hammad N; Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Pramesh CS; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Aggarwal A; Institute of Cancer Policy, King's College London, London, UK; London School of Hygiene and Tropical Medicine, London, UK.
  • Sullivan R; Institute of Cancer Policy, King's College London, London, UK.
  • Booth CM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada. Electronic address: booth@que
Clin Oncol (R Coll Radiol) ; 34(1): 28-35, 2022 01.
Article em En | MEDLINE | ID: mdl-34479769
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Indústria Farmacêutica / Oncologia Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Indústria Farmacêutica / Oncologia Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Ano de publicação: 2022 Tipo de documento: Article